Dossiers d'AMM à étudier par le Comité Technique des Spécialités Pharmaceutiques du 27/05/2020.
Spécialités Pharmaceutiques importées :
* Produits déjà évalués lors des derniers Comités Techniques
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de la demande | DATE RE |
1 | IBRANCE | PALBOCICLIB | 75mg | Gélule | B/21 | PFIZER INC USA | E | N | 13/03/2020 |
2 | IBRANCE | PALBOCICLIB | 100mg | Gélule | B/21 | PFIZER INC USA | E | N | 13/03/2020 |
3 | IBRANCE | PALBOCICLIB | 125mg | Gélule | B/21 | PFIZER INC USA | E | N | 13/03/2020 |
* Produits à évaluer pour la première fois au Comité Technique
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de la demande | DATE RE |
1 | FOSAVANCE | Alendronate +Cholecalciferol | 570/5600 UI | COMPRIME | B/4 | MSD PAYS BAS | E | N | Transfert du 22/05/2019 |
2 | ZELDOX | ZIPRASIDONE | 20 MG/ML | PDRE PR PREP INJ | B/1FL+S/1,2ML | PFIZER GMbH | E | V | CS 25/11/2019 |
3 | ABILIFY | ARIPIPRAZOLE | 15 MG | COMP | B/28 | ABDI IBRAHIM OTSUKA | E | V | CS 25/11/2019 |
4 | ABILIFY | ARIPIPRAZOLE | 10 MG | COMP | B/28 | ABDI IBRAHIM OTSUKA | E | V | CS 25/11/2019 |
5 | GILENYA | FINGOLIMOD | 0,5 MG | GELULE | B/28 | NOVARTIS PHARMA | V | CS 25/11/2019 | |
6 | UTROGESTAN | PROGESTERONE | 100 MG | CAPSULE MOLLE | B/30 | BESINS INT | E | V | CS 26/11/2019 |
7 | RHOPHYLAC | IMMUNOGLOBUNE HUMAINE ANTI D | 300µG/2ML | SERINGUE PRE REMPL | B/1 | CSL BEHRINGER | E | V | CS 26/11/2019 |
8 | CRESTOR | ROSUVASTATINE | 5 MG | COMP PELLICULE | B/30 | ASTRAZENECA | E | V | CS 26/11/2019 |
9 | CRESTOR | ROSUVASTATINE | 20 MG | COMP PELLICULE | B/30 | ASTRAZENECA | E | V | CS 26/11/2019 |
10 | CRESTOR | ROSUVASTATINE | 10 MG | COMP PELLICULE | B/30 | ASTRAZENECA | E | V | CS 26/11/2019 |
11 | TRESIBA | INSULINE DEGLUDEG | 200 UI/ML | SOL INJ | B/3 | NOVO NORDISK | V | V | CS 26/11/2019 |
12 | TRESIBA FLEXTOUCH | INSULINE DEGLUDEG | 100 UI/ML | SOL INJ | B/5 | NOVO NORDISK | V | V | CS 26/11/2019 |
13 | XELJANZ | TOFACITINIB | 5 MG | COMPRIME | B/60 | PFIZER PAYS BAS | E | V | CS 26/11/2019 |
14 | IMMUNORHO | IMMUNOGLOBUNE HUMAINE ANTI D | 300µG | PDRE PR PREP INJ | B/1FL | KEDRION S.P.A | E | V | CS 26/11/2019 |
15 | COMBIVIR | LAMIVUDINE+ZIDOVUDINE | 150mg/300mg | COMP PELLICULE SECABLE | B/60 | ViiV Healthcare BV | E | N | TRANSFERT 26/11/2019 |
16 | EPIVIR | LAMIVUDINE | 150 mg | COMP PELLICULE SECABLE | FL/60 | ViiV Healthcare BV | E | N | TRANSFERT 26/11/2019 |
17 | RETROVIR | ZIDOVUDINE | 100 mg | GELULE | B/100 | ViiV Healthcare BV | E | N | TRANSFERT 26/11/2019 |
18 | TOBREX | TOBRAMYCINE | 0.3% | COLLYRE | FL/5ML | NOVARTIS PHARMA AG (Bâle Suisse) | E | V | TRANSFERT avec variation 27/11/2019 |
19 | KISQALI | RIBOCICLIB SUCINATE | 200 MG | COMP PEL | B/63 | NOVARTIS PHARMA SCHWEIZ AG | V | N | 05/12/2019 |
20 | RAPIFEN | ALFENTANIL | 1 mg (0.5mg/ml) | SOL INJ | B/5/2 ML | Piramal Critical Care Limited | V | N | TRANSFERT 06/12/2019 |
21 | DARZALEX | Daratumumab | 20mg/ml | SOL INJ | B/1FL/5ML | Janssen-Cilag International N.V | N | CS 03/12/2019 | |
22 | DARZALEX | Daratumumab | 20mg/ml | SOL INJ | B/1FL/20ML | Janssen-Cilag International N.V | N | CS 03/12/2019 | |
23 | VENCLYXTO | VENETOCLAX | 10 mg | COMP PELL | B/14 | ABBVIE DEUTSCHLAND Gmbh and Co.KG | N | CS 03/12/2019 | |
24 | PURINETHOL | MERCAPTOPURINE | 50 MG | COMP SECABLE | FL/25 | ASPEN PHARMA | V | V | CS 03/12/2019 |
25 | TASIGNA | NILOTINIB | 150 mg | GELULE | B/112 | NOVARTIS PHARMA | V | V | CS 03/12/2019 |
26 | TASIGNA | NILOTINIB | 200 mg | GELULE | B/28 | NOVARTIS PHARMA | V | V | CS 03/12/2019 |
27 | IMBRUVICA | IBRUTINIB | 140 MG | GELULE | B/90 | Janssen-Cilag International N.V | E | V | CS 03/12/2019 |
28 | VENCLYXTO | VENETOCLAX | 100 mg | COMP PEL | B/7 | ABBVIE ltd | N | CS 03/12/2019 | |
29 | VENCLYXTO | VENETOCLAX | 50 mg | COMP PEL | B/7 | ABBVIE ltd | N | CS 03/12/2019 | |
30 | VENCLYXTO | VENETOCLAX | 10 mg | COMP PEL | B/14 | ABBVIE ltd | N | CS 03/12/2019 | |
31 | VENCLYXTO | VENETOCLAX | 100 mg | COMP PEL | B/14 | ABBVIE ltd | N | CS 03/12/2019 | |
32 | VENCLYXTO | VENETOCLAX | 100 mg | COMP PEL | B/112 | ABBVIE ltd | N | CS 03/12/2019 | |
33 | ZIAGEN | ABACAVIR | 300 mg | COMP PEL | B/60 | ViiV Healthcare BV | E | N | Transfert 04/12/2019 |
34 | VIAGRA | SILDENAFIL | 25 MG | COMP PEL | B/4 | PFIZER Europe MA EEIG | c | N | TRANSFERT 09/12/2019 |
35 | VIAGRA | SILDENAFIL | 50 MG | COMP PEL | B/4 | PFIZER Europe MA EEIG | c | N | TRANSFERT 16/12/2019 |
36 | VIAGRA | SILDENAFIL | 100 MG | COMP PEL | B/4 | PFIZER Europe MA EEIG | c | N | TRANSFERT 16/12/2019 |
37 | INVANZ | ERTAPENEM | 1 GR | PDRE PR PREP INJ | B/1F/15ML | Merck Sharp & Dohme Ltd R.U | E | N | CS 20/12/2019 |
38 | RIFOCINE | RIFAMYCINE | 250 MG | SOL INJ | B/1FL/3ML | SANOFI AVENTIS SPA | E | V | CS 20/12/2019 |
39 | PREVENAR 13 | VACCIN PNEUMOCOCCIQUE | NA | SUSP INJ | B/1seringue pré-remplie/0.5ml | PFIZER Europe MA EEIG | I | N | TRANSFERT 20/12/2019 |
40 | SOLICARE | SOLIFENACINE SUCCINATE | 5 mg | COMP PEL | B/30 | GENEPHARM S.A | E | N | 20/12/2019 |
41 | SOLICARE | SOLIFENACINE SUCCINATE | 10 mg | COMP PEL | B/30 | GENEPHARM S.A | E | N | 20/12/2019 |
42 | RILUZOLE MYLAN 50 | RILUZOLE | 50 mg | COMP PEL | B/56 | MYLAN S.A.S | E | N | 24/12/2019 |
43 | DUPHASTON | DYDROGESTERONE | 10 MG | COMP | B/10 | Abbott B.V | E | N | TRANSFERT 25/12/2019 |
44 | RHESONATIV | IMMUNOGLOBUNE HUMAINE ANTI D | 625 UI/ML | SOL INJ | B/1/2ML | OCTAPHARMA | E | V | 25/12/2019 |
45 | KETODERM 2% GEL EN SACHET | KETOCONAZOLE | 2% | GEL DERMIQUE | B/8/6 GR | EG LABO - Laboratoires Eurogenerics SAS | E | N | TRANSFERT 31/12/2019 |
46 | XOLAIR | OMALIZUMAB | 150 mg | PDRE PR SOL INJ | B/1F | NOVARTIS PHARMA AG | V | CS 06/01/2020 | |
47 | BRICANYL LP | TERBUTALINE | 5 MG | COMP LP | FL/60 | ASTRA ZENECA | E | V | CS 06/01/2020 |
48 | ELIQUIS | APIXABAN | 5 MG | COMP PEL | B/20 | Bristol-Myers Squibb/Pfizr EEIG | E | N | CS 06/01/2020 |
49 | ELIQUIS | APIXABAN | 5 MG | COMP PEL | B/60 | Bristol-Myers Squibb/Pfizr EEIG | E | N | CS 06/01/2020 |
50 | ELIQUIS | APIXABAN | 2,5MG | COMP PEL | B/20 | Bristol-Myers Squibb/Pfizr EEIG | E | N | TRANSFERT CS 06/01/2020 |
51 | ELIQUIS | APIXABAN | 5 MG | COMP PEL | B/20 | Bristol-Myers Squibb/Pfizr EEIG | E | N | TRANSFERT CS 06/01/2020 |
52 | SUXAMETHONIUM-LABESFAL | SUXAMETHONIUM | 100 MG/2ML | SOL INJ | B/100/2ML | LABESFAL | V | V | CS 06/01/2020 |
53 | DESLORATADINE GENEPHARM | DESLORATADINE | 5 MG | COMP | B/30 | GENEPHARM S.A | E | N | 15/01/2020 |
54 | DESLORATADINE GENEPHARM | DESLORATADINE | 2,5 MG | COMP | B/30 | GENEPHARM S.A | E | N | 15/01/2020 |
55 | LEVONORGESTREL MYLAN | LEVONORGESTREL | 1.5 mg | COMP | B/1 | MYLAN S.A.S | E | N | 15/01/2020 |
56 | VAXIGRIP | VACCIN ANTIGRIPPE | SUSP INJ | B/1SER/0,5 ML | SANOFI PASTEUR SA | I | V | CS 17/01/2020 | |
57 | JADENU | DEFERASIROX | 360MG | COMP PEL | B/30 | NOVARTIS PHARMA SCHWEIZ AG | V | N | 22/01/2020 |
58 | JADENU | DEFERASIROX | 180MG | COMP PEL | B/90 | NOVARTIS PHARMA | V | N | 22/01/2020 |
59 | JADENU | DEFERASIROX | 90MG | COMP PEL | B/90 | NOVARTIS PHARMA | V | N | 22/01/2020 |
60 | VESOMNI | SOLIFENACINE+ TAMSULOSINE | 6mg/0.4mg | COMP | B/30 | ASTELLAS PHARMA EUROPE B.V HOLLANDE | N | 22/01/2020 | |
61 | TOMEC | DORZOLAMIDE+ TIMOLOL | 100 mg/ 25mg | COLLYRE | FL/5 ml | ABDI IBRAHIM IIac San. ve Tic. A.S. | E | N | 22/01/2020 |
62 | OFNOL | OLOPATADINE | 0.1% | COLLYRE | FL/5 ml | ABDI IBRAHIM IIac San. ve Tic. A.S. | E | N | 04/02/2020 |
63 | ORAP | PIMOZIDE | 4 MG | COMP | B/30 | EUMEDICA PHARMACEUTICALS GmbH | E | N | TRANSFERT 04/02/2020 |
64 | LYRICA | PREGABALINE | 75 mg | GEL | B/56 | PFIZER Europe MA EEIG | V | N | TRANSFERT 04/02/2020 |
65 | LYRICA | PREGABALINE | 75 mg | GEL | B/56 | PFIZER Europe MA EEIG | V | N | TRANSFERT 04/02/2020 |
66 | LYRICA | PREGABALINE | 150 mg | GEL | B/14 | PFIZER Europe MA EEIG | V | N | TRANSFERT 04/02/2020 |
67 | ALECENSA | ALECTINIB | 150 MG | GELULE | B/224 | ROCHE PHARMA (SCHWEIZ) LTD SUISSE | N | 10/02/2020 | |
68 | REDDITUX | RITUXIMAB | 500 mg/50ml | SOL INJ | B/1FL | DR REDDY'S LABORATORIES LTD | V | N | CS 13/02/2020 |
69 | REDDITUX | RITUXIMAB | 100 mg/10ml | SOL INJ | B/1FL | DR REDDY'S LABORATORIES LTD | V | N | CS 13/02/2020 |
70 | NOCDURNA | DESMOPRESSINE | 50 µg | LYOPHI ORAL | B/30 | FERRING ARZNEIMITTEL GmbH | E | N | 17/02/2020 |
71 | NOCDURNA | DESMOPRESSINE | 25 µg | LYOPHI ORAL | B/30 | FERRING ARZNEIMITTEL GmbH | E | N | 17/02/2020 |
72 | TOBREX | TOBRAMYCINE | 0.3% | pommade ophtalmo | Tube/3.5 gr | NOVARTIS PHARMA SCHWEIZ AG | E | N | 17/02/2020 |
73 | TOBRADEX | DEXAMETHASONE+ TOBRAMYCINE | 100 mg/300 mg | COLLYRE | FL/5 ml | NOVARTIS PHARMA SCHWEIZ AG | E | N | 17/02/2020 |
74 | DIPIPERON | PIPAMPERONE | 40 MG | COMP | B/20 | EUMEDICA PHARMACEUTICALS GmbH | E | N | Transfert 19/02/2020 |
75 | COSENTYX | SECUKINUMAB | 150MG/ML | SOL INJ | B/2 seringues pré_remplis | NOVARTIS EUROPHARM LIMITED IRLANDE | E | N | Transfert 21/02/2020 |
76 | COSENTYX | SECUKINUMAB | 150MG/ML | SOL INJ | B/2 Stylos pré_remplis | NOVARTIS EUROPHARM LIMITED IRLANDE | E | N | Transfert 21/02/2020 |
77 | ENBREL | ETANERCEPT | 50 mg | SOL INJ | B/4 stylos pré-remplis | PFIZER Europe MA EEIG | E | N | Transfert 21/02/2020 |
78 | ENBREL | ETANERCEPT | 25 mg | SOL INJ | B/4 seringues pré-remplis | PFIZER Europe MA EEIG | E | N | Transfert 21/02/2020 |
79 | STOCRIN | EFAVIRENZ | 30mg/ml | SOL BUVABLE | B/ 01 flacon de 180 ml | MSD PAYS BAS | V | N | 16/04/2020 |
80 | PROGESTAN | PROGESTERONE | 100 MG | CAPSULE MOLLE | B/30 | BESINS INTERNATIONAL | E | N | RE 07/05/2020 |
81 | PROGESTAN | PROGESTERONE | 200 MG | CAPSULE MOLLE | B/15 | BESINS INTERNATIONAL | E | N | RE 07/05/2020 |
82 | REFACTO AF | FACTEUR VIII | 1000 UI | POUDRE P PREPARATION INJECTABLE | b/1fl+ seringue | PFIZER Europe MA EEIG | V | N | TRANSFERT DU 07/05/2020 |
83 | REFACTO AF | FACTEUR VIII | 500 UI | POUDRE P PREPARATION INJECTABLE | b/1fl+ seringue | PFIZER Europe MA EEIG | V | N | TRANSFERT DU 07/05/2020 |
84 | REFACTO AF | FACTEUR VIII | 250 UI | POUDRE P PREPARATION INJECTABLE | b/1fl+ seringue | PFIZER Europe MA EEIG | V | N | TRANSFERT DU 07/05/2020 |
85 | FORXIGA | DAPAGLIFLOZINE | 5 MG | COMPRIME | B/28 | ASTRA ZENECA | E | N | RE du 08/05/2020 |
86 | FORXIGA | DAPAGLIFLOZINE | 10 MG | COMPRIME | B/28 | ASTRA ZENECA | E | N | RE du 08/05/2020 |
87 | JANUVIA | SITAGLIPTINE | 100 MG | COMPPRIME | B/28 | MSD PAYS BAS | E | N | TRANSFERT DU 08/05/2020 |
88 | REDEX | TADALAFIL | 5 MG | COMPRIME | B/28 | ATTAQADDOM JORDANIE | C | N | RE 12/05/2020 |
89 | REDEX | TADALAFIL | 10MG | COMPRIME | B/2 | ATTAQADDOM JORDANIE | C | N | RE 12/05/2020 |
90 | REDEX | TADALAFIL | 75MG | COMPRIME | B/2 | ATTAQADDOM JORDANIE | C | N | RE 12/05/2020 |
91 | MERIONAL HG | GONODOTROPHINE MENOPAUSIQUE HUMAINE | 150 UI/ML | POUDRE P PREPARATION INJECTABLE | B/1FL+AP DE SOLVANT | IBSA BIOCHIMIQUE SA SUISSE | E | N | RE du 26/05/2020 |
92 | MERIONAL HG | GONODOTROPHINE MENOPAUSIQUE HUMAINE | 75 UI/ML | POUDRE P PREPARATION INJECTABLE | B/1FL+AP DE SOLVANT | IBSA BIOCHIMIQUE SA SUISSE | E | N | RE du 26/05/2020 |
Spécialités Pharmaceutiques fabriquées localement:
* Produits déjà évalués lors des derniers Comités Techniques
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de demande | DATE Rapport |
1 | THERACELL | DASATINIB | 50 mg | Comprimé pelliculé | B/60 | THERA | E | N | 26/10/2018 |
2 | THERACELL | DASATINIB | 70 mg | Comprimé pelliculé | B/60 | THERA | E | N | 26/10/2018 |
6 | RIVA | RIVAROXABAN | 20 mg | Comprimé pelliculé | B/30 | PHILADELPHIA PHARMA | E | N | 30/07/2018 |
5 | RIVA | RIVAROXABAN | 20 mg | Comprimé pelliculé | B/10 | PHILADELPHIA PHARMA | E | N | 30/07/2018 |
4 | RIVA | RIVAROXABAN | 15 mg | Comprimé pelliculé | B/42 | PHILADELPHIA PHARMA | E | N | 30/07/2018 |
3 | RIVA | RIVAROXABAN | 15 mg | Comprimé pelliculé | B/28 | PHILADELPHIA PHARMA | E | N | 30/07/2018 |
5 | PARAMED | PARACETAMOL | 10 mg/ml | Solution injectable pour perfu | B/6 poches multicouches/50ML | UNIMED | E | N | 16/01/2019 |
6 | ACARBOSE ADWYA | ACARBOSE | 50 mg | Comprimé sécable | B/90 | ADWYA | E | N | 28/02/2019 |
7 | ACARBOSE ADWYA | ACARBOSE | 100 mg | Comprimé sécable | B/90 | ADWYA | E | N | 28/02/2019 |
8 | CANDESAR PLUS | CANDESARTAN CILEXETIL+HYDROCHLOROTHIAZIDE | 8 mg/12.5 mg | Comprimé | B/90 | DAR-ESSAYDALI. | E | N | 19/01/2018 |
9 | CANDESAR PLUS | CANDESARTAN CILEXETIL+HYDROCHLOROTHIAZIDE | 8 mg/12.5 mg | Comprimé | B/30 | DAR-ESSAYDALI. | E | N | 19/01/2018 |
10 | CANDESAR PLUS | CANDESARTAN CILEXETIL+HYDROCHLOROTHIAZIDE | 16 mg/12.5 mg | Comprimé | B/90 | DAR-ESSAYDALI. | E | N | 26/01/2018 |
11 | CANDESAR PLUS | CANDESARTAN CILEXETIL+HYDROCHLOROTHIAZIDE | 16 mg/12.5 mg | Comprimé | B/30 | DAR-ESSAYDALI. | E | N | 19/01/2018 |
12 | MILEXO | BROMAZEPAM | 6 mg | Comprimé quadrisécable | T/30 | TERIAK | E | N | 27/04/2018 |
13 | CLAMOXYL | AMOXICILLINE | 125 mg | Poudre pour suspension orale | FL/60 ML | ADWYA | E | V | CS 07/04/2017 |
14 | CLAMOXYL | AMOXICILLINE | 500 mg | Comprimé soluble | B/12 | ADWYA | E | V | CS 07/04/2017 |
15 | CLAMOXYL | AMOXICILLINE | 250 mg | Poudre pour suspension orale | FL/60 ML | ADWYA | E | V | CS 07/04/2017 |
16 | CLAMOXYL | AMOXICILLINE | 500 mg | Poudre pour suspension orale | FL/60 ML | ADWYA | E | V | CS 07/04/2017 |
17 | CLAMOXYL DISPERSIBLE | AMOXICILLINE | 500 mg | Comprimé soluble | B/12 | ADWYA | E | V | CS 07/04/2017 |
18 | CLAMOXYL DISPERSIBLE | AMOXICILLINE | 1 GR | Comprimé soluble | B/12 | ADWYA | E | V | CS 07/04/2017 |
20 | ICATENS | AMLODIPINE+VALSARTAN | 10MG/160MG | Comprimé pelliculé | B/30 | GALPHARMA | E | N | 05/09/2017 |
19 | ICATENS | AMLODIPINE+VALSARTAN | 5 MG/160MG | Comprimé pelliculé | B/30 | GALPHARMA | E | N | 05/09/2017 |
21 | ROSULIP | ROSUVASTATINE | 5 mg | Comprimé pelliculé | B/30 | TERIAK | E | N | 19/06/2017 |
22 | ROSULIP | ROSUVASTATINE | 10mg | Comprimé pelliculé | B/30 | TERIAK | E | N | 19/06/2017 |
23 | ROSULIP | ROSUVASTATINE | 20 mg | Comprimé pelliculé | B/30 | TERIAK | E | N | 19/06/2017 |
24 | RESPIROX | RISPERIDONE | 2 mg | Comprimé | B/20 | IBN AL BAYTAR | E | N | 22/01/2020 |
25 | RESPIROX | RISPERIDONE | 4 MG | Comprimé | B/30 | IBN AL BAYTAR | E | N | 22/01/2020 |
* Produits à évaluer pour la première fois au Comité Technique
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de demande | DATE Rapport |
1 | ZITRO | AZITHROMYCINE | 500 mg | Comprimé pelliculé | B/30 | LES LABORATOIRES MEDIS | E | N | 01/05/2020 |
2 | SCLERA | DIMETHYLFUMARATE | 120 mg | Gélule gastrorésistante | B/14 | IBN AL BAYTAR | E | N | 12/05/2020 |
3 | SCLERA | DIMETHYLFUMARATE | 240 mg | Gélule gastrorésistante | B/60 | IBN AL BAYTAR | E | N | 12/05/2020 |
4 | PREDNICORT | PREDNISOLONE | 5 mg | Comprimé orodispersible | B/30 | PHARMACARE | E | N | 12/05/2020 |
5 | PREDNICORT | PREDNISOLONE | 20 mg | Comprimé orodispersible | B/30 | PHARMACARE | E | N | 12/05/2020 |
6 | RIVAROXABAN | RIVAROXABAN | 10 | Comprimé pelliculé | B/10 | TERIAK | E | N | 17/05/2020 |
7 | RIVAROXABAN | RIVAROXABAN | 10 | Comprimé pelliculé | B/30 | TERIAK | E | N | 18/05/2020 |
8 | RIVAROXABAN | RIVAROXABAN | 15 mg | Comprimé pelliculé | B/40 | TERIAK | E | N | 16/05/2020 |
9 | RIVAROXABAN | RIVAROXABAN | 20 mg | Comprimé pelliculé | B/10 | TERIAK | E | N | 14/05/2020 |
10 | RIVAROXABAN | RIVAROXABAN | 20 mg | Comprimé pelliculé | B/30 | TERIAK | E | N | 13/05/2020 |
11 | AZRO 1200 MG | AZITHROMYCINE | 40 mg/ ml | Poudre pour suspension orale | FL/30 ml | TERIAK | E | N | 12/05/2020 |
12 | TENSIOVALS DUO | AMLODIPINE+VALSARTAN | 5mg/80mg | Comprimé pelliculé | B/30 | TAHA PHARMA | E | V | 28/05/2020 |
13 | TENSIOVALS DUO | AMLODIPINE+VALSARTAN | 5mg/160mg | Comprimé pelliculé | B/30 | TAHA PHARMA | E | V | 38/05/2020 |
14 | TENSIOVALS DUO | AMLODIPINE+VALSARTAN | 10mg/160mg | Comprimé pelliculé | B/30 | TAHA PHARMA | E | V | 28/05/2020 |
15 | HEPARINE UNIMED | HEPARINE SODIQUE | 25000 UI/5ml | Solution injectable | B/10 | UNIMED | E | N | 12/05/2020 |
16 | CYTODOX | DOXORUBICINE | 10 mg/ 5 ml | Solution injectable pour perfu | B/1 flacon/5ml | CYTOPHARMA | V | N | 21/05/2020 |
17 | CYTODOX | DOXORUBICINE | 50mg /25ml | Solution injectable pour perfu | B/1 flacon/25ml | CYTOPHARMA | V | N | 21/05/2020 |